Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +6.47% | +10.37% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lamine Mbow
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Douglas Bakan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Megan Knight
IRC | Investor Relations Contact | - | - |
Corporate Secretary | - | - |
Company contact information
Arena Pharmaceuticals, Inc.
136 Heber Avenue Suite 204
84060-5237, Park City
+858 453 7200
http://www.arenapharm.comSector
- Stock Market
- Equities
- ARNA Stock
- RN3N Stock
- Company Arena Pharmaceuticals